The 84th Annual Meeting of the Japanese Society of Hematology

Japanese

Invited Speakers

Listed in alphabetical order as of April 28

Dr. Jun-ichi Abe Jun-ichi Abe
(University of Texas MD Anderson Cancer Center, USA)

Speaker Symposium 4
Cardio-oncology: Where do we come from? What are we? Where are we going?
 Ash A. Alizadeh Ash A. Alizadeh
(Moghadam Family Professor of Medicine Divisions of Oncology & Hematology Stanford Cancer Institute, USA)

Speaker Special Symposium
Molecular Profiling of Lymphomas Using Circulating Tumor DNA
  Antonio Almeida Antonio Almeida
(Hospital da Luz Lisboa Católica Medical School, Portugal)

Chair JSH-EHA Joint Symposium
Recent advances in the management of lymphoid malignancies
Speaker EHA Special Lecture
Challenges in the Diagnosis and Treatment of Chronic Myelomonocytic Leukemia
Prof. Suning Chen Suning Chen
(Jiangsu Institute of Hematology. The First afffiliated hospital of Soochow Unviersity, China)

Speaker Asian Joint Panel Discussion
Current status of acute promyelocytic leukemia in China.
Prof. Jean Marie Connors Jean Marie Connors
(Harvard Medical School Brigham and Women's Hospital Dana-Farber Cancer Institute, USA)

Speaker Symposium 4
COVID Associated Thrombosis—What We Know in 2022
commentator SETP (Scientific Exchange Training Program)
Hemostasis/Thrombosis and COVID-19
Dr. Yelena Ginzburg Yelena Ginzburg
(Icahn School of Medicine at Mount Sinai, USA)

Speaker Symposium 2
Novel mechanisms of ineffective erythropoiesis in β-thalassemia
Prof. Hsin-An Hou Hsin-An Hou
(Internal Medicine (Division of Hematology) , National Taiwan University Hospital, Taiwan)

Speaker Asian Joint Panel Discussion
Current status, challenges and clinical relevance of targeted therapy in Taiwan AML patients
Dr. Martin Hutchings Martin Hutchings
(Department of Haematology, Rigshospitalet and University of Copenhagen, Denmark)

Speaker JSH-EHA Joint Symposium
CD3XCD20 bispecific antidodies for B-cell lymphoma
Dr. James Kochenderfer James Kochenderfer
(National Cancer Institute, National Institutes of Health, USA)

Speaker JSH-ASH Joint Symposium
Anti-BCMA CAR T-cell therapy for multiple myeloma
Dr. Diane Krause Diane Krause
(Yale University, USA)

Speaker Symposium 2
Regulation of Megakaryocytic-Erythroid Progenitor Fate Specification
Dr. Dan Landau Dan Landau
(WCM/NYGC, USA)

Speaker Symposium 1
Somatic evolutionin normal and neoplastic hematopoiesis through the lens of single-cell multi-omics
Prof. Vikram Mathews Vikram Mathews
(Dept of Haematology, Christian Medical College, India)

Speaker Asian Joint Panel Discussion
Promise and challenges with targeted therapy in AML: a perspective from India
Prof. Adam J Mead Adam J Mead
(University of Oxford, UK)

Speaker Symposium 1
Genetic and Non-Genetic Determinants of Disease Progression in Myeloproliferative Neoplasms
Prof. Alberto Orfao Alberto Orfao
(University of Salamanca, Spain)

Speaker Symposium 6
Detection of minimal residual disease in multiple myeloma: application for clinical care
Prof. Marco Ruella Marco Ruella
(Center for Cellular Immunotherapy, University of Pennsylvania, USA)

Speaker JSH-ASH Joint Symposium
CD5 knock out enhances the anti-tumor activity of chimeric antigen receptor T cells
Dr. David Sallman David Sallman
(Moffitt Cancer Center, USA)

Speaker Symposium 5
Targeting CD47/SIRPα axis for the treatment of MDS/AML
Prof. Dong Yeop Shin Dong Yeop Shin
(Internal Medicine, Seoul National University Hospital, Korea)

Speaker Asian Joint Panel Discussion
Molecular targeting therapy for AML in Korea
 Liran Shlush Liran Shlush
(Weizmann institute of science, Israel)

Speaker Symposium 1
Mutation mechanisms in clonal hematopoiesis
Dr. Catherine Smith Catherine Smith
(University of California San Francisco, USA)

Speaker Symposium 5
Resistance to FLT3 Inhibitors in AML
Dr. Sampath Venkata Sreekanth Sampath Venkata Sreekanth
(The Department of Haematology, Tan Tock Seng Hospital, Singapore)

Chair Asian Joint Panel Discussion
Recent progresses of molecular targeting therapy: how has it changed AML therapy in Asia?
Speaker Asian Joint Panel Discussion
How I Use Venetoclax in Acute Myeloid Leukemia
Dr. Adisak Tantiworawit Adisak Tantiworawit
(Internal Medicine, ChiangMai University, Thailand)

Speaker Asian Joint Panel Discussion
Molecular target for FLT3-mutated AML: Data from Thai Acute Leukemia Working Group
Prof. Hervé Tilly Hervé Tilly
(Department of Hematology, Centre Henri-Becquerel, Rouen, France)

Speaker JSH-EHA Joint Symposium
Antibody drug conjugates in the treatment of B-cell lymphomas
Prof. Jeffrey W. Tyner Jeffrey W. Tyner
(Knight Cancer Institute, Oregon Health & Science University, USA)

Speaker Symposium 5
Big Data for Novel Therapeutic Strategies in Myeloid Malignancies
commentator SETP (Scientific Exchange Training Program)
Acute Myeloid Leukemia
Dr. Brian A Walker Brian A Walker
(Indiana University School of Medicine, USA)

Speaker Symposium 6
Molecular biomarkers of MM in clinical practice –advances and perspectives
commentator SETP (Scientific Exchange Training Program)
Multiple MyelomaMultiple Myeloma
Prof. Andrew Wei Andrew Wei
(Peter MacCallum Cancer Centre Walter and Eliza Hall Institute, Australia)

Speaker Symposium 5
Venetoclax in AML: what we have learned
 Irving Weissman Irving Weissman
(Institute for Stem Cell Biology and Regenerative Medicine / Stanford Ludwig Center for Cancer Stem Cell Research and Medicine, USA)
Speaker Special Lecture
Normal and Neoplastic Stem Cells
Prof.  Jane N. Winter Jane N. Winter
(Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, USA)

Chair JSH-ASH Joint Symposium
CAR-T Therapy from the Bench to the Clinic and Back
Speaker ASH Special Lecture
Diffuse Large B-cell Lymphoma: 2022 Update
commentator SETP (Scientific Exchange Training Program)
Malignant Lymphoma
Prof. Jun J Yang Jun J Yang
(St. Jude Children’s Research Hospital, USA)

Speaker Symposium 3
Pharmacogenomic Landscape of Acute Lymphoblastic Leukemia
Prof. Jinghui Zhang Jinghui Zhang
(St Jude Children's Research Hospital, USA)

Speaker Special Symposium
Utility of Whole Genome Sequencing in Clinical Profiling of Pediatric Cancer
Copyright © The 84th Annual Meeting of the Japanese Society of Hematology All Rights Reserved.